Filter
728
Text search:
controlled
drugs
Featured
Recommendations
89
New Publications
149
Language
Document type
No document type
422
Guidelines
129
Studies & Reports
93
Manuals
38
Strategic & Response Plan
20
Fact sheets
12
Training Material
10
Situation Updates
2
Brochures
1
Resource Platforms
1
Countries / Regions
India
41
Kenya
21
South Africa
19
Western and Central Europe
17
Latin America and the Carribbean
15
Global
15
Ethiopia
14
Nigeria
13
Eastern Europe
13
Uganda
11
Malawi
11
Tanzania
10
Ukraine
10
Sierra Leone
9
Ghana
9
Philippines
9
Syria
9
Rwanda
9
Nepal
8
Africa
8
Liberia
7
Zimbabwe
7
South Sudan
7
Zambia
7
South–East Asia Region
7
Russia
6
Bangladesh
5
Congo, Democratic Republic of
4
Namibia
4
Colombia
4
Botswana
4
Myanmar / Burma
4
Yemen
4
Asia
4
Guinea
3
Afghanistan
3
Cambodia
3
Thailand
3
Indonesia
3
Sudan
3
Eswatini/ Swaziland
3
Lesotho
3
Tajikistan
3
USA
2
Cameroon
2
Haiti
2
Germany
2
Lebanon
2
Mozambique
2
Brazil
2
Hungary
2
Madagascar
2
Mexico
2
East and Southern Africa
2
Venezuela
2
Kyrgyzstan
2
Burkina Faso
1
Senegal
1
Mali
1
Morocco
1
Somalia
1
Iraq
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
North Macedonia
1
Ecuador
1
Libya
1
Sri Lanka
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Poland
1
Palestine
1
Armenia
1
Laos
1
Lithuania
1
Iran
1
Kazakhstan
1
Georgia
1
Vietnam
1
Gabon
1
Jamaica
1
Denmark
1
Mauritius
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
222
Clinical Guidelines
103
Public Health
46
Women & Child Health
41
Key Resources
26
Pharmacy & Technologies
9
Capacity Building
6
Toolboxes
Mental Health
106
HIV
76
TB
70
COVID-19
35
NTDs
30
AMR
26
Caregiver
25
Pharmacy
24
NCDs
22
Conflict
18
Ebola & Marburg
12
Refugee
11
Disability
10
Rapid Response
8
Malaria
7
Natural Hazards
6
Planetary Health
6
Cholera
5
Specific Hazards
4
Global Health Education
4
Polio
3
Zika
3
Social Ethics
1
Health Financing Toolbox
1
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic only?
Factors to take into account when choosing, reviewing and changing medicines.
Rescue therapy:
For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved.
Diet and lifestyle advice:
At each point reinforce advice about diet and life
...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply
...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an
...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
Accessed: 07.11.2019
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
Session outline
•Introduction to epilepsy.
•Assessment of epilepsy.
•Management of epilepsy.
•Follow-up of a person with epilepsy.
•Review or materials and skills.
An Evidence-Based Treatment Guide for Clinicians
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th
...